UBQ-8i Polymorphism is not An Independent Risk Factor for Mild Cognitive Impairment and Alzheimer’s Disease in APOE-4 Carriers

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|9|4|467-472

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.9, Iss.4, 2012-05, pp. : 467-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ApoE −491A/T Promoter Polymorphism is not an Independent Risk Factor, but Associated with the ε4 Allele in Hungarian Alzheimer’s Dementia Population

By Juhász Anna Palotás András Janka Zoltán Rimanóczy Ágnes Palotás Miklós Bódi Nikoletta Boda Krisztina Zana Marianna Vincze Gábor Kálmán János

Neurochemical Research, Vol. 30, Iss. 5, 2005-05 ,pp. : 591-596

Springer Publishing Company

Access to resources Recommend Favorite

MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study

By Gattaz Wagner Talib Leda Schaeffer Evelin Diniz Breno Forlenza Orestes

Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. : 193-200

Springer Publishing Company

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F. Forlenza O. V. Talib L. L. Barbosa N. R. Bottino C. M. C.

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Comparing regional brain atrophy in mild cognitive impairment and Alzheimer’s disease

By Weiler Marina Cendes Fernando Balthazar Marcio LF

Neurodegenerative Disease Management, Vol. 3, Iss. 5, 2013-10 ,pp. : 417-426

Future Medicine

Access to resources Recommend Favorite